Next Article in Journal
Influence of Sodium Lauryl Sulfate and Tween 80 on Carbamazepine–Nicotinamide Cocrystal Solubility and Dissolution Behaviour
Next Article in Special Issue
Liposome Formulation of Fullerene-Based Molecular Diagnostic and Therapeutic Agents
Previous Article in Journal / Special Issue
Proteoliposomes as Tool for Assaying Membrane Transporter Functions and Interactions with Xenobiotics

Advances in Lipid Nanoparticles for siRNA Delivery

Department of Biochemistry and Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, B.C. V6T 1Z3, Canada
Author to whom correspondence should be addressed.
Pharmaceutics 2013, 5(3), 498-507;
Received: 1 July 2013 / Revised: 4 September 2013 / Accepted: 12 September 2013 / Published: 18 September 2013
(This article belongs to the Special Issue Liposome Technologies)
Technological advances in both siRNA (small interfering RNA) and whole genome sequencing have demonstrated great potential in translating genetic information into siRNA-based drugs to halt the synthesis of most disease-causing proteins. Despite its powerful promises as a drug, siRNA requires a sophisticated delivery vehicle because of its rapid degradation in the circulation, inefficient accumulation in target tissues and inability to cross cell membranes to access the cytoplasm where it functions. Lipid nanoparticle (LNP) containing ionizable amino lipids is the leading delivery technology for siRNA, with five products in clinical trials and more in the pipeline. Here, we focus on the technological advances behind these potent systems for siRNA-mediated gene silencing. View Full-Text
Keywords: lipid nanoparticle; siRNA; ionizable amino lipid; pKa; PEG lipid; targeting lipid nanoparticle; siRNA; ionizable amino lipid; pKa; PEG lipid; targeting
Show Figures

Figure 1

MDPI and ACS Style

Tam, Y.Y.C.; Chen, S.; Cullis, P.R. Advances in Lipid Nanoparticles for siRNA Delivery. Pharmaceutics 2013, 5, 498-507.

AMA Style

Tam YYC, Chen S, Cullis PR. Advances in Lipid Nanoparticles for siRNA Delivery. Pharmaceutics. 2013; 5(3):498-507.

Chicago/Turabian Style

Tam, Yuen Y.C., Sam Chen, and Pieter R. Cullis. 2013. "Advances in Lipid Nanoparticles for siRNA Delivery" Pharmaceutics 5, no. 3: 498-507.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop